Amgen (AMGN) Earnings Date, Estimates & Call Transcripts $289.02 +0.15 (+0.05%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$286.25 -2.77 (-0.96%) As of 02/4/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Amgen Latest Earnings SummaryLatest Q4 2024 Earnings DateFeb. 4EstimatedActual EPS (Feb. 4) $5.31 Beat By $0.27 Consensus EPS (Feb. 4) $5.04 Amgen issued Q4 2024 earnings on February 4, 2025, reporting an EPS of $5.31, which beat analysts' consensus estimates of $5.04 by $0.27. With a trailing EPS of $7.81 and a P/E Ratio of 37.01, Amgen's earnings are expected to grow 4.96% next year, from $19.56 to $20.53 per share. Conference Call Get Amgen Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amgen and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAMGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Amgen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252$4.56$5.11$4.84 Q2 20252$5.03$5.58$5.31 Q3 20252$5.21$5.95$5.58 Q4 20252$4.25$5.25$4.75 FY 20258$19.05$21.89$20.47 Q1 20261$4.67$4.67$4.67 Q2 20261$5.13$5.13$5.13 Q3 20261$5.42$5.42$5.42 Amgen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails2/4/2025Q4 2024$5.04$5.31+$0.27$1.16$8.87B-10/30/2024Q3 2024$5.11$5.58+$0.47$5.94$8.50B$8.50B8/6/2024Q2 2024$5.01$4.97 -$0.04$8.56$8.35B$8.39B5/2/2024Q1 2024$3.76$3.96+$0.20$8.13$7.45B$7.45B2/6/2024Q4 2023$4.66$4.71+$0.05$8.00$8.13B$8.20B10/31/2023Q3 2023$4.65$4.96+$0.31$6.70$6.92B$6.90B8/3/2023Q2 2023$4.44$5.00+$0.56$7.43$6.66B$7.00B4/27/2023Q1 2023$3.84$3.98+$0.14$2.68$6.18B$6.11B2/7/2023Q4 2022$4.04$4.09+$0.05$5.18$6.77B$6.84B Amgen Earnings - Frequently Asked Questions When did Amgen announce their last quarterly earnings? Amgen (NASDAQ:AMGN) last announced its quarterly earning data on Tuesday, February 4, 2025. Learn more on AMGN's earnings history. What guidance has Amgen issued on next quarter's earnings? Amgen updated its FY 2025 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of 20.000-21.200 for the period, compared to the consensus EPS estimate of 20.820. The company issued revenue guidance of $34.3 billion-$35.7 billion, compared to the consensus revenue estimate of $34.5 billion. Did Amgen beat their earnings estimates last quarter? In the previous quarter, Amgen (NASDAQ:AMGN) reported $5.31 earnings per share (EPS) to beat the analysts' consensus estimate of $5.04 by $0.27. Learn more on analysts' earnings estimate vs. AMGN's actual earnings. How can I listen to Amgen's earnings conference call? The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded annual revenue of $28.19 billion. How much profit does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded net income of $6.72 billion. AMGN has generated $7.81 earnings per share over the last four quarters. What is Amgen's price-to-earnings ratio? Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 37.01 and a forward price-to-earnings ratio of 14.78. The price/earnings-to-growth ratio is 2.87. What is Amgen's EPS forecast for next year? Amgen's earnings are expected to grow from $19.56 per share to $20.53 per share in the next year, which is a 4.96% increase. More Earnings Resources from MarketBeat Related Companies Gilead Sciences Earnings Results Vertex Pharmaceuticals Earnings Results Regeneron Pharmaceuticals Earnings Results Alnylam Pharmaceuticals Earnings Results Biogen Earnings Results United Therapeutics Earnings Results Neurocrine Biosciences Earnings Results Incyte Earnings Results BioMarin Pharmaceutical Earnings Results Exact Sciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Surges After Blockbuster Earnings: What's Next?Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip? This page (NASDAQ:AMGN) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
